Clinical trial · Observational
Remote Collection of Patient Reported Toxicity Using SMS Text Messaging (CareSignal)
Remote Collection of Patient Reported Toxicity Using SMS Text Messaging
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
CareSignal has developed an application that allows for remote collection of patient-reported data such as symptoms or outcomes on any device compatible with the short message service (SMS), otherwise known as "text messaging". The software can be configured to complete symptom monitoring by surveying patients about toxicity using the PRO-CTCAE tools. PRO-CTCAE is the patient reported outcomes version of the CTCAE that was designed by the National Cancer Institute (NCI) for use in clinical trials.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CareSignal | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- CareSignal
- description
- -Participants will undergo a single training session on how to use the CareSignal software no more than 4 weeks before starting standard of care therapy. After the training session, patients will be encouraged by the treatment team to complete the baseline symptom report once they receive the questions via SMS prior to starting any therapy and to complete the weekly reports during therapy and in follow up.
- interventionNames
- Other: CareSignal
Primary outcomes (2)
- measure
- Percentage of invited symptom reports completed during the study period
- timeFrame
- From treatment through 30 days follow-up (estimated to be 3 months)
- measure
- Percentage of questions completed within each invited symptom report
- timeFrame
- From treatment through 30 days follow-up (estimated to be 3 months)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Currently planning to receive radiotherapy for 2 or more fractions with or without chemotherapy. * Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable). * Age 18 years or older. Exclusion Criteria: -Unable to reliably access and use a device compatible with CareSignal software.
References
Publications (0)
Data not yet available